| Date | Title | Description | Source |
| 20.10.2023 | Early-stage pharmaceutical companies make strides in cancer-... |
Schlieren-based biotech startup ImmunOs Therapeutics AG develops HLA-based therapeutics to combat ... | startuptic... |
| 15.05.2023 | Numab TherapeutIcs doses first patient with eczema |
Atopic dermatitis (AD), also referred to as eczema, is an inflammatory skin condition characterize... | startuptic... |
| 04.04.2022 | Numab signs a CHF 258 million deal with Ono Pharmaceuticles |
Numab Therapeutics is creating multi-specific antibodies based on proprietary MATCH technology pla... | startuptic... |
| 20.05.2021 | Numab Therapeutics Completes CHF 100 Million Series C Financ... |
Numab Therapeutics aims to write the next chapter in cancer immunotherapy by creating multi-specif... | startuptic... |
| 20.05.2021 | Numab Therapeutics Completes Oversubscribed CHF 100 Million ... | Numab Therapeutics AG, a clinical stage biopharmaceutical company developing next-generation multisp... | marketscre... |
| 20.05.2021 | Numab Therapeutics Completes CHF 100 Million Series C Financ... | Numab Therapeutics aims to write the next chapter in cancer immunotherapy by creating multi-specific... | startuptic... |
| 20.05.2021 | Numab raises $111M to challenge Genmab, BioNTech for emergin... | Numab Therapeutics has raised CHF 100 million ($111 million) to expand clinical development of its l... | fiercebiot... |
| 20.05.2021 | Numab Therapeutics completes oversubscribed CHF 100 million ... | Numab Therapeutics completes oversubscribed CHF 100 million Series C financing 20.05.2021 17:35, Isa... | venturelab... |
| 13.01.2021 | Numab Therapeutics signs co-development partnership with Jap... |
Numab Therapeutics is an oncology-focused biopharmaceutical company is developing multi-specific a... | startuptic... |
| 13.01.2021 | Numab Therapeutics signs co-development partnership with Jap... | Numab Therapeutics is an oncology-focused biopharmaceutical company is developing multi-specific ant... | startuptic... |
| 05.10.2020 | Startups win strong and well-connected board members | NBE Therapeutics, Erich Schlick, chairman of the board of Director
NBE-Therapeutics, a biotech compa... | startuptic... |
| 05.10.2020 | Startups win strong and well-connected board members |
NBE Therapeutics, Erich Schlick, chairman of the board of Director
NBE-Therapeutics, a biotech com... | startuptic... |
| 24.08.2020 | Numab Therapeutics advances to the clinical trials stage | Numab Therapeutics is an oncology-focused biopharmaceutical company is developing multi-specific ant... | startuptic... |
| 24.08.2020 | Numab Therapeutics advances to the clinical trials stage |
Numab Therapeutics is an oncology-focused biopharmaceutical company is developing multi-specific a... | startuptic... |
| 09.07.2020 | Boehringer Ingelheim to Develop Antibody Therapeutics with N... |
Numab Therapeutics and Boehringer Ingelheim today announced that they have entered into a research... | startuptic... |
| 09.07.2020 | Boehringer Ingelheim to Develop Antibody Therapeutics with N... | Numab Therapeutics and Boehringer Ingelheim today announced that they have entered into a research c... | startuptic... |
| 30.03.2020 | Numab Therapeutics to receive additional CHF 260M from its J... |
The Zurich based Numab Therapeutics is focusing on the development of multi-specific antibodies ba... | startuptic... |
| 30.03.2020 | Numab Therapeutics to receive additional CHF 260M from its J... | The Zurich based Numab Therapeutics is focusing on the development of multi-specific antibodies base... | startuptic... |
| 09.03.2020 | MUFG Capital joins Zurich-based Numab Therapeutics’ $22.6m S... | Premium
Zurich-based biotech company Numab Therapeutics has snagged a total of $22.6 million in its... | dealstreet... |
| 09.03.2020 | Numab Therapeutics raises CHF 22M series B round |
Numab Therapeutics is an oncology-focused biopharmaceutical company developing a pipeline of multi... | startuptic... |
| 09.03.2020 | Mitsubishi joins Eisai, 3SBio's bet on multispecific a... | Following a busy year of dealmaking, Swiss antibody shop Numab has closed a Series B at CHF2... | endpts.com... |
| 09.03.2020 | Vasella helps Numab to CHF22M round ahead of cancer trial st... | Numab Therapeutics has raised CHF 22 million ($23.8 million) ahead of the start of clinical testing ... | fiercebiot... |
| 09.03.2020 | Numab Therapeutics raises CHF 22M series B round | Numab Therapeutics is an oncology-focused biopharmaceutical company developing a pipeline of multi-s... | startuptic... |
| 09.03.2020 | Swiss Biotech Numab Therapeutics raises CHF 22 million | Swiss Biotech Numab Therapeutics raises CHF 22 million 09.03.2020 15:38, Gianmaria Sbetta linkedIn f... | venturelab... |
| 09.03.2020 | Vasella helps Numab to CHF22M round ahead of cancer trial st... | Numab Therapeutics has raised CHF 22 million ($23.8 million) ahead of the start of clinical testing ... | fiercebiot... |
| 17.12.2019 | Biotech Startup Numab Therapeutics Raises CHF 15 Series B Ro... | Biotech Startup Numab Therapeutics Raises CHF 15 Series B Round 17.12.2019 13:52, Gianmaria Sbetta l... | venturelab... |
| 13.12.2019 | A new partner and investor for Numab |
Numab Therapeutics is a biotech startup specialising in the development of multi-specific antibodi... | startuptic... |
| 16.10.2019 | Daniel Vasella joins biotech startup |
Founded in 2011, Numab develops a proprietary pipeline of multi-specific biotherapeutics in immuno... | startuptic... |
| 01.10.2019 | Eisai teams up with Numab to generate cancer therapeutics |
Numab Therapeutics AG (Numab) today announced the initiation of a partnership with Eisai, Co., Ltd... | startuptic... |
| 03.05.2019 | Numab signs licensing deal with Chinese biopharmaceutical co... |
Pursuant to the terms of the licensing agreement, CStone will fund the research and development of... | startuptic... |
| 15.09.2017 | Intarcia and Numab Reach Key Milestone |
This milestone, achieved by utilizing Numab’s innovative discovery and optimization platform to id... | startuptic... |
| 16.06.2017 | Numab achieves milestones and signs new partnerships |
For the partnership with Intarcia, Numab applied its novel discovery and optimization platform to ... | startuptic... |
| 29.03.2017 | Profitable deal for Numab |
Under the agreement, Ono Pharmaceutical Co., Ltd. (Ono) will obtain an option to acquire intellect... | startuptic... |
| 09.06.2015 | Tillotts and Numab conclude license agreement |
Tillotts Pharma AG and Numab AG announced today that they have entered into an exclusive global li... | startuptic... |
| 20.03.2015 | Intarcia and Numab to develop once-yearly therapies in diabe... |
Intarcia Therapeutics, Inc. and Numab AG today announced a strategic collaboration focused on the ... | startuptic... |
| 12.06.2014 | Milestone payment for Numab |
In the course of the collaboration Numab discovered novel anti-TNFa molecules meeting predefined s... | startuptic... |
| 30.10.2013 | Numab Reacquires Advanced Compound from Sucampo |
“ND003 is being developed for topical administration to the lung in patients suffering from severe... | startuptic... |
| 25.10.2013 | CEO Day 2013: a huge and efficient event - updated |
At the beginning of this year’s CEO Day organizer Jean-Pierre Vuilleumier showed an impressive gro... | startuptic... |
| 31.07.2013 | Robert Kamen Joins Numab’s Advisory Board |
Robert Kamen has more than 30 years of experience in the pharmaceutical and biotechnology industry... | startuptic... |
| 19.03.2013 | Numab Earns Milestone Payment from Sucampo |
Numab AG, a Swiss biotech company focused on the discovery and development of innovative antibody-... | startuptic... |
| 18.12.2012 | Numab Nominates Burkhard Becher Scientific Advisor | In 2003 Burkhard was recruited as Assistant Professor to the University Hospital of Zurich and in 20... | startuptic... |
| 07.12.2012 | More start-ups than ever at the Swiss Venture Day |
It was a hard day for the 40+ investors and business angels: They saw presentations of eight very ... | startuptic... |
| 23.11.2012 | Eight promising start-ups present at the next Swiss Venture ... |
At the 39th Swiss Venture Day for the first time eight companies will present to VCs and business ... | startuptic... |
| 20.06.2012 | CTI Start-up Label for Numab, Qvanteq, SwissTV and Virometix |
IfjInstLA 14.00 Normal 0 21 false false false DE-CH X-NONE X-NONE Three of the four companies are ... | startuptic... |
| 12.06.2012 | Grow Wädenswil im Aufwärtstrend |
Normal 0 21 false false false DE-CH X-NONE X-NONE Rund 100 Besucher strömten gestern Abend zum Jub... | startuptic... |
| 06.02.2012 | Ex-Esbatech employees are building up a new company |
Oliver Middendorp 14.00 Normal 0 21 false false false DE-CH X-NONE X-NONE Oliver Middendorp and Da... | startuptic... |
